You are here:
Following the launch of their glaucoma referral pathway earlier this year, the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has today (Saturday 19 November) launched the next stage of the project with the two more referral pathways. The RANZCO Referral Pathway for Age-related Macular Degeneration (AMD) Management and the RANZCO Referral Pathway for Diabetic Retinopathy Management are launched today at the RANZCO Annual Scientific Congress in Melbourne at workshops held to share the information with optometrists and GPs.
“RANZCO is committed to working collaboratively with optometrists, GPs and other health care professionals to ensure the most effective and efficient patient care and to improve ye health outcomes for people across Australia and New Zealand,” explained incoming RANZCO President Associate Professor Mark Daniell. “As with the Glaucoma Pathway, the AMD and Diabetic Retinopathy Pathways have been developed with the input of both ophthalmologists and optometrists and they aim to provide a clear guide for referring patients to ophthalmologists. The pathways are being made available to all optometrists and GPs and we are keen to get feedback from those who to use them so that we can continue to build on and improve the guidelines.”
The RANZCO Referral Pathway for Age-related Macular Degeneration (AMD) Management and the RANZCO Referral Pathway for Diabetic Retinopathy Management are now available.
For more information or to arrange an interview contact Emma Carr or Laura Safaj at RANZCO 02 9690 1001 or at email@example.com
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) is the professional body for ophthalmologists — eye doctors — in Australia and New Zealand. The College acts as the voice of the profession for its 1600 members and is responsible for the training, examining and professional development of Ophthalmologists. Our mission is to drive improvements in eye healthcare in Australia, New Zealand and the Asia-Pacific region through continuing exceptional training, education, research and advocacy.